Publication | Closed Access
Bleomycin-Mediated Pulmonary Toxicity
54
Citations
43
References
2000
Year
Acute Lung InjuryLung InflammationApoptosisPathologyCell DeathCancer BiologyBleomycin Damages DnaRespiratory ToxicologyPulmonary PharmacologyMg BleomycinToxicologyCancer ResearchBleomycin-mediated Pulmonary ToxicityPulmonary FibrosisPulmonary MedicinePharmacologyCell BiologyLung CancerInhalation ToxicologyMedicineLung Injury
Bleomycin damages DNA and causes lung injury and fibrosis. To determine whether bleomycin is associated with the appearance of DNA damage-inducible proteins, C3H mice received either 0.4 mg bleomycin or normal saline intratracheally and were killed 1 to 14 d later. The lungs were examined for expression of p53, p21(WAF1/PiCl), and proliferating cell nuclear antigen (PCNA) using immunohistochemistry and Western blotting. p53-positive cells first appeared at 5 d after treatment and peaked at 7 d; PCNA-positive cells appeared at 1 d after treatment and peaked at 7 d; and p21-positive cells appeared at 5 d and peaked at 9 d. Western blot analysis confirmed that bleomycin upregulated the DNA damage-inducible proteins in a similar fashion. This is the first evidence that bleomycin causes a p53-dependent response associated with acute injury in the lung.
| Year | Citations | |
|---|---|---|
Page 1
Page 1